This Article  • PDF of this Correction  • Original article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Neurology  • Cerebrovascular Disease  • Stroke  • Cardiovascular System  • Prognosis/ Outcomes  • Cardiovascular Disease/ Myocardial Infarction  • Drug Therapy  • Drug Therapy, Other  • Endocrine Diseases  • Diabetes Mellitus  • Alert me on articles by topic  Social Bookmarking   What's this?

JAMA. 2009;301(18):1882.

Incorrect Data in Text and Table: In the Original Contribution titled "Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 Diabetes: A Randomized Controlled Trial," published in the November 12, 2008, issue of JAMA (2008;300[18]:2134-2141), incorrect numbers of adverse events appeared in the text and in 1 table. On page 2137 in the last paragraph, the second sentence should have read, "The hemorrhagic events consisted of GI bleeding in 12 patients in the aspirin group and 4 in the nonaspirin group and retinal hemorrhage in 8 patients in the aspirin group and 5 in the nonaspirin group." In Table 3 on page 2139, the data for the Nonaspirin Group in the row Retinal bleeding should have been 5 and in the row Subcutaneous hemorrhage should have been 1.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?